• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Smiths Medical debuts drug pump software

November 10, 2016 By Sarah Faulkner

Smiths Medical debuts drug pump softwareSmiths Group (LON:SMIN) Smiths Medical division today launched an updated version of its PharmGuard interoperability software for its Medfusion 4000 wireless syringe pumps.

The new version features bi-directional integration with any IHE compatible electronic medical record system, the company said. Smart pump programming allows a clinician order to be sent directly to the Medfusion pump, so nurses can validate the programmed information with less manual entry.

The PharmGuard interoperability software was released in 2015 and facilitates wireless communication of infusion data directly into patient records, which saves time in the clinician’s daily workflow, boosts accurate book-keeping, and improves patient safety by reducing manual data entry errors.

The software can also forward infusion pump alarms to hospital alarm management system to alert clinicians, Smiths Medical said.

The St. Paul, Minn-based company’s Medfusion Pump 4000 was approved in September 2011.

This week, Smiths Group said that it divested its Wallace in-vitro fertilization product line to Cooper Cos. (NYSE:COO) CooperSurgical subsidiary for $174 million (UK £140 million).

The divestiture is part of an ongoing program at Smiths to focus its portfolio on “market leading positions of scale in its chosen markets,” the company said. The company said that proceeds from the sale will be reinvested in “attractive growth opportunities.”

The Wallace division reported revenues of $24.9 million (UK £20 million) for its year ended July 31, 2016, with $14.9 million (UK £12 million) in operating profit.

Filed Under: Business/Financial News, Featured, mHealth (Mobile Health), Technology Tagged With: Smiths Group, Smiths Medical

IN CASE YOU MISSED IT

  • Another BD Alaris infusion pump recall is Class I
  • Amgen completes $1.9B acquisition of Five Prime Therapeutics
  • Oncopeptides seeks EU marketing authorization for multiple myeloma treatment
  • Horizon touts data from trials for thyroid eye disease infusion treatment
  • Genentech touts study results for spinal muscular atrophy drug in babies

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS